These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2019568)

  • 1. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure.
    Horiuchi S; Araki N; Morino Y
    J Biol Chem; 1991 Apr; 266(12):7329-32. PubMed ID: 2019568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
    Ikeda K; Higashi T; Sano H; Jinnouchi Y; Yoshida M; Araki T; Ueda S; Horiuchi S
    Biochemistry; 1996 Jun; 35(24):8075-83. PubMed ID: 8672512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of antibodies to advanced glycation products on proteins.
    Nakayama H; Taneda S; Kuwajima S; Aoki S; Kuroda Y; Misawa K; Nakagawa S
    Biochem Biophys Res Commun; 1989 Jul; 162(2):740-5. PubMed ID: 2474294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry.
    Miki Hayashi C; Nagai R; Miyazaki K; Hayase F; Araki T; Ono T; Horiuchi S
    Lab Invest; 2002 Jun; 82(6):795-808. PubMed ID: 12065691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging.
    Araki N; Ueno N; Chakrabarti B; Morino Y; Horiuchi S
    J Biol Chem; 1992 May; 267(15):10211-4. PubMed ID: 1587810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
    Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
    Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo.
    Obayashi H; Nakano K; Shigeta H; Yamaguchi M; Yoshimori K; Fukui M; Fujii M; Kitagawa Y; Nakamura N; Nakamura K; Nakazawa Y; Ienaga K; Ohta M; Nishimura M; Fukui I; Kondo M
    Biochem Biophys Res Commun; 1996 Sep; 226(1):37-41. PubMed ID: 8806589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products of the Maillard reaction and their relation to aging.
    Horiuchi S; Araki N
    Gerontology; 1994; 40 Suppl 2():10-5. PubMed ID: 7926861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
    Shibayama R; Araki N; Nagai R; Horiuchi S
    Diabetes; 1999 Sep; 48(9):1842-9. PubMed ID: 10480617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transepithelial flux of early and advanced glycation compounds across Caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems.
    Grunwald S; Krause R; Bruch M; Henle T; Brandsch M
    Br J Nutr; 2006 Jun; 95(6):1221-8. PubMed ID: 16768847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
    Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
    Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
    Booth AA; Khalifah RG; Todd P; Hudson BG
    J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antibodies to advanced glycosylation end products on protein.
    Nakayama H; Taneda S; Mitsuhashi T; Kuwajima S; Aoki S; Kuroda Y; Misawa K; Yanagisawa K; Nakagawa S
    J Immunol Methods; 1991 Jun; 140(1):119-25. PubMed ID: 1905740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
    Koito W; Araki T; Horiuchi S; Nagai R
    J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
    Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
    J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
    Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
    Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.